EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cdk5 modulates orofacial pain through P2X2/3 purinergic receptor-mediated signaling in trigeminal neurons

Rodrigo Sandoval, Nicolás Pinto-Pardo, Camila Duran, Patricio Castro, Gabriela Rossi, Christian González-Billault, María Pertusa, Rodolfo Madrid, Claudio Coddou, Elías Utreras

Frontiers in Pharmacology · 04.05.2026 · 17

DOI: 10.3389/fphar.2026.1767160 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 04.05.2026. Verfasst von Rodrigo Sandoval und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Faculty of Science, Universidad de Chile, Santiago, Chile. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cyclin-dependent kinase 5 (Cdk5) plays a critical role in pain transmission by phosphorylating key nociceptive proteins. One of its recently identified substrates, the P2X2 subunit, is part of the P2X2/3 purinergic receptor (P2X2/3R), which is implicated in nociceptive signaling. However, the specific contribution of Cdk5 to purinergic receptor-mediated pain responses remains unclear. This study aimed to investigate the role of Cdk5 in pain responses elicited by α,β-methylene ATP (α,β-meATP), an agonist of P2X2/3R and P2X3R.

Methods

Both pharmacological inhibition and genetic loss-of-function approaches were used to assess the role of Cdk5. Calcium (Ca 2+ ) imaging was performed in cultured murine trigeminal ganglion (TG) neurons to characterize α,β-meATP-evoked responses. Surface biotinylation assays in HEK293 cells were used to assess P2X2 receptor membrane expression. In vivo , facial pain was induced by injecting α,β-meATP into the whisker pad of mice. Behavioral responses were evaluated in conditional Cdk5 knockout mice targeting sensory neurons and in control littermates.

Results

In TG neuron cultures, α,β-meATP evoked both fast and slow Ca 2+ transients, which were sensitive to P2X3 or P2X2/3 channel blockade. Inhibition or genetic loss-of-function of Cdk5 predominantly accelerated the decay of slow responses, with minimal effects on fast responses. In HEK293 cells, Cdk5 activation did not alter the surface expression of P2X2 receptors. In vivo , α,β-meATP induced facial pain-like behaviors, including grooming and head flinching, which were significantly reduced in conditional Cdk5 knockout mice compared to controls.

Discussion

These findings indicate that Cdk5 modulates orofacial pain by regulating purinergic receptor-mediated signaling in trigeminal neurons. Specifically, Cdk5 appears to influence the functional properties of P2X2-containing channels, most likely P2X2/3 heteromeric receptors, without affecting their membrane expression. This modulation of receptor kinetics may underlie the observed changes in nociceptive behavior, highlighting Cdk5 and P2X receptors as a potential target for pain modulation.

Schlagwörter

Stichwörter der Autor:innen

ATP-gated channelsCdk5p35phosphorylationpurinergic signaling

Autor:innen und Institutionen

  • Department of Biology, Faculty of Science, Universidad de Chile, Santiago, Chile.
  • Dentistry, Department of Dental Sciences, Faculty of Life Sciences, Universidad Viña del Mar, Viña del Mar, Chile.
  • Department of Biomedical Sciences, Faculty of Medicine, Universidad Católica del Norte, Coquimbo, Chile.
  • Department of Physiology, Faculty of Biological Sciences, Universidad de Concepción, Concepción, Chile.
  • Department of Neurosciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.
  • Geroscience Center for Brain Health and Metabolism, Santiago, Chile.

Zitieren

APA

Sandoval, R., Pinto-Pardo, N., Duran, C., Castro, P., Rossi, G., González-Billault, C., Pertusa, M., Madrid, R., Coddou, C., & Utreras, E. (2026). Cdk5 modulates orofacial pain through P2X2/3 purinergic receptor-mediated signaling in trigeminal neurons. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1767160

Vancouver

Sandoval R, Pinto-Pardo N, Duran C, Castro P, Rossi G, González-Billault C, et al. Cdk5 modulates orofacial pain through P2X2/3 purinergic receptor-mediated signaling in trigeminal neurons. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1767160

BibTeX
@article{Sandoval2026,
  author = {Sandoval, Rodrigo and Pinto-Pardo, Nicolás and Duran, Camila and Castro, Patricio and Rossi, Gabriela and González-Billault, Christian and Pertusa, María and Madrid, Rodolfo and Coddou, Claudio and Utreras, Elías},
  title = {Cdk5 modulates orofacial pain through P2X2/3 purinergic receptor-mediated signaling in trigeminal neurons},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1767160}
}
Kostenlos starten →